The feasibility of a newly developed local network system for cardiac rehabilitation (the CR-GNet) in disease management and physical fitness after acute coronary syndrome

Funding Acknowledgements

Type of funding sources: Foundation. Main funding source(s): Grant-in-aid from.jpgu Prefecture

Background

The newly developed Cardiac Rehabilitation.jpgu Network (CR-GNet) has been implemented to create a regional alliance network and to provide periodic follow-up examinations to enhance the disease management in patients with cardiovascular disease. The effectiveness of a network like this support system has not yet been evaluated in Japan.

Purpose

We aimed to examine the feasibility of the CR-GNet in disease management, assisting patients in attaining physical fitness and its impact on long-term outcomes after acute coronary syndrome (ACS).

Methods

We enrolled 47 patients with ACS in the CR-GNet between February 2016 and September 2019; of these, 37, 29, and 21 patients underwent follow-up assessments for exercise capacity (peak oxygen uptake) at 3 months, 6 months, and 1 year after discharge, respectively. Major adverse cardiac events (MACE) were defined as the composite of death from cardiac causes, cardiac arrest, myocardial infarction, and rehospitalization due to unstable or progressive angina. MACE were compared with controls who were not registered in the CR-GNet.

Results

The coronary risk factors, except blood pressure, improved at 3 and 6 months, and 1 year after discharge. These risk factors in each patient significantly reduced from 2.9 at admission to 1.6, 1.4, and 1.9 at 3 months, 6 months, and 1 year after discharge (p < 0.05), respectively. Peak oxygen uptake was significantly higher at 3 months, 6 months, and 1 year after discharge to 17.5 ± 4.9 ml/kg/min, 17.9 ± 5.1 ml/kg/min, and 17.5 ± 5.5 ml/kg/min, respectively, than that at discharge (14.7 ± 3.6 ml/kg/min) (p < 0.05). During follow-up, there was no significant difference; MACE did not occur in any patients in the CR-GNet but occurred in controls.

Conclusions

The CR-GNet is a feasible option for long-term management of ACS patients. The prognostic impact of the CR-GNet needs further investigation with a larger sample size and longer follow-up.

Table1 At admission 3 months 6 months 1 year Average number 2.9 1.6* 1.4** 1.9*** † Average number of coronary risk factors for all patients (n = 21) p = 0.004, vs. at admission; **p = 0.001, vs. at admission; ***p = 0.011, vs. at admission; †p = 0.035, vs. at 6 months

[Maternal behavior. Induction of biological regulation in the animal]

The author assesses the current state of knowledge of the neuroendocrinological mechanisms in the induction of maternal behavior in animals in the immediate prepartum (nesting behavior) and in the post-partum, and of the mechanisms involved in the maintenance of this behavior (principally, feed-back from offsprings). Oxytocine (OT) appears very important for the induction of maternal behavior because of central targets of the parvocellular system of the hypothalamus. In fact, we have observed that parturition produces modifications in the RNAm of OT and of OT receptors: both in number and Bmax. An artificial induction of the behavior, outside parturition, is possible to a certain extent after a central, intra-cisternal, administration of OT. Other neuro-hormones have an important role: the modification of the balance of oestroprogestatives at the end of gestancy is absolutely necessary, vasopressin, endogeneous opioids which have a facilitatory effect, may be by an indirect stimulation of OT. Maternal behavior may also be artificially induced by a cervico-vaginal stimulation of a female virgin. Olfactive mechanisms are vital for behavioral specificity, which varies among different races. In primates, the developement of the neocortex is associated with the supremacy of social factors, but it is probable that similar neuroendocrinological mechanisms operate.

[Prostaglandins E1 and psychopathogeny of schizophrenia]

The authors assess the results of several studies, fundamental or clinical with therapeutic tests, to demonstrate a possible role of prostaglandins--specially of a possible lack of PGE1--in the pathogeny of certain forms of schizophrenia. The heterogeneousness of the results leads one to think there's heterogeneousness of the illness. Meanwhile, in certain cases, the contribution of a direct precursor of PGE1 the GLA, has given possible noticeable clinical results, mainly with deficiency symptoms.